OPTIMAL-STROKE: Lower Cardiovascular Risk With Intensive BP Target

Key Takeaways
- Among people in Brazil with elevated BP and previous ischemic stroke or TIA, the primary cardiovascular composite occurred in 10.9% assigned intensive treatment versus 13.5% assigned standard treatment, a statistically significant difference.
- The composite renal outcome was more common under intensive treatment.
- Overall serious adverse-event incidence was similar across treatment groups.
Investigators enrolled 4,368 participants with elevated BP and previous ischemic stroke or TIA in the multicenter, open-label, randomized OPTIMAL-STROKE trial in the New England Journal of Medicine at 30 sites in Brazil. They assigned 2,172 participants to an intensive systolic target of <120 mm Hg and 2,196 to a standard target of <140 mm Hg; these were assigned targets, not achieved pressures. Median follow-up was 3.9 years. The primary composite comprised cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina or heart failure. The renal composite comprised a sustained reduction of at least 50% in estimated glomerular filtration rate (eGFR) or progression to end-stage renal disease.
After excluding the first three months of follow-up, achieved mean systolic BP was 122.0 mm Hg in the intensive group versus 135.2 mm Hg in the standard group, a between-group mean difference of 13.1 mm Hg. The primary cardiovascular composite occurred in 236 participants assigned intensive treatment versus 297 assigned standard treatment.
For the intensive-versus-standard comparison, the primary composite had a hazard ratio of 0.79 (95% confidence interval (CI), 0.67 to 0.94; P=0.007). The composite renal outcome was more common with intensive treatment, whereas overall serious adverse-event incidence was similar between groups.
The open-label design and exclusively Brazilian sites frame interpretation of the assigned strategies in this population. The cardiovascular and renal findings concern separate composite outcomes rather than every possible consequence of lowering BP after a cerebrovascular event.
Investigators concluded that assignment to the lower systolic target resulted in fewer major cardiovascular composite events among participants with previous ischemic stroke or TIA, alongside a less favorable renal-composite finding.
Clinician Questions
Did intensive blood-pressure targeting independently lower recurrent stroke after ischemic stroke or TIA?
Among participants with elevated blood pressure and previous ischemic stroke or transient ischemic attack, nonfatal stroke was one component of the cardiovascular composite evaluated in OPTIMAL-STROKE, but the trial results do not establish a separate reduction in recurrent stroke.
What were the age and sex characteristics of participants with prior ischemic stroke or TIA in OPTIMAL-STROKE?
OPTIMAL-STROKE participants had elevated blood pressure and previous ischemic stroke or transient ischemic attack; mean age was 63.9±11.2 years, and 2,093 participants (47.9%) were women.
Recommended Reading
- For more on preventing recurrent ischemic stroke: Bayer Reports Asundexian Approval for Secondary Stroke Prevention
This content is intended for healthcare professionals for educational purposes. The article and its image were developed with AI assistance and reviewed by members of the ReachMD team prior to publication. Please refer to the original source linked for the complete and most up-to-date information.